Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Ophthalmology · Xuanwu Hospital · Beijing

Dr. Dai Weijia戴惟葭

Chief Physician · Associate Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Dai Weijia

Professional overview

Dr. Dai Weijia is a Chief Physician and Associate Professor in the Department of Ophthalmology at Xuanwu Hospital, specializing in glaucoma, cataract, optic nerve diseases, and ophthalmic laser therapy.

SpecialtyOphthalmology
Clinical titleChief Physician
Academic rolesAssociate Professor, Doctoral Supervisor
DepartmentOphthalmology
HospitalXuanwu Hospital
CityBeijing

Areas of focus

GlaucomaFocuses on early diagnosis and treatment of primary glaucoma, especially early acute angle-closure glaucoma; conducts clinical screening and guidance for acute angle-closure glaucoma.
CataractSkilled in combined glaucoma and cataract treatment.
Optic nerve diseaseConducts neuro-ophthalmology research, particularly on optic nerve protection.
Ophthalmic laser therapyHas extensive clinical experience in ophthalmic laser therapy, including laser iridoplasty and krypton laser peripheral iridoplasty combined with Nd:YAG laser peripheral iridotomy.

Background

  • 1997First author of 'Application of proliferating cell nuclear antigen in human trabecular cell proliferation research' in Chinese Journal of Ophthalmology
  • 1998First author of 'Human trabecular cell culture and passage experiment in vitro' in Chinese Journal of Ophthalmology
  • 1998First author of 'Application of macular photopic threshold detection in glaucoma research' in Chinese Journal of Practical Ophthalmology
  • 2004First author of 'Therapeutic significance of intraocular pressure-lowering drugs in normal-tension glaucoma' in Ophthalmic Research
  • 2007First author of 'Evaluation of krypton laser peripheral iridoplasty combined with Nd:YAG laser peripheral iridotomy for early angle-closure glaucoma' in Chinese Journal of Practical Ophthalmology
  • 2007First author of 'Comparison and reflection on training of ophthalmology residents in China and abroad' in Northwest Medical Education
  • 2008First author of 'Human optic nerve head astrocyte cells culture in vitro' in Chinese Medical Journal
  • 2008First author of 'The preferred treatment for primary acute angle-closure glaucoma: laser iridoplasty' in Ophthalmic New Advances

Experience & recognition

  • Recipient of Beijing 'Ten-Hundred-Thousand' Talent Project in Health System (2002)
  • Recipient of award for 'Experimental studies of growth of trabecular cells on the filters and hydraulic conductivity' (1998)
  • Recipient of award for 'Research on macular photopic threshold in glaucoma' (1992)

Professional roles

  • Member, Chinese Medical Association (CMA)
  • Member, Canadian International Ophthalmological Society

Frequently asked questions

What does Dr. Dai Weijia specialize in?

Specializes in glaucoma, cataract, optic nerve diseases, and ophthalmic laser therapy.

Which hospital and department is Dr. Dai Weijia in?

Department of Ophthalmology at Xuanwu Hospital

Sources

Dr. Dai Weijia has not reviewed this page.